Fundraising Fox
/Companies
Sign in

A28 Therapeutics

La Jolla, US · Founded 2021 · Delaware corporation

Find your way into A28 Therapeutics

45 people in our graph share verified history with the A28 Therapeutics team — schools, employers, funds. One of them is your warm intro.

Rod Cottonunlockedknows Stanley Lewis · together at The Just Society (overlapped)
×9knows the team · via Johnson & Johnson
×2knows the team · via Pennington Biomedical Research Center

A28 Therapeutics develops a targeted oncolytic peptide platform for treating multiple cancer types, with its lead candidate AT-101 in late-stage development for metastatic ovarian cancer with liver metastases and hepatocellular carcinoma. The company is also exploring combinations of AT-101 with immuno-oncology drugs and chemotherapy.

BiotechHealthtechMedical Devices

Founders & leadership

A28 Therapeutics was founded in 2021 by Stanley Lewis.

SLStanley Lewis
Stanley LewisFounder and CEOStanley Lewis is a physician and founder and CEO of A28 Therapeutics, a clinical-stage biotechnology company developing targeted oncolytic peptides for cancer treatment. He previously served as Chief Medical Officer of Ansun Biopharma, where he led late-stage clinical trials for parainfluenza, influenza, and COVID-19 therapies, and as Chief Medical Officer of TaiMed Biologics, where he oversaw development and FDA approval of TROGARZO for multi-drug resistant HIV. He holds an MD from the University of Texas McGovern Medical School and an MPH from the University of Texas School of Public Health.

Board

RB
ROSS BARRETTBoard director

Reported raises · per SEC filings

Form D private placements

$1.9M disclosed across 1 round · 2022

▶$1.9MraisedJan 2025 · 26 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • STANLEY LEWISExecutive Officer, Director
  • ROSS BARRETTDirector
Offering amount
$1.9M
Amount sold
$1.9M
First sale
Feb 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap
Bioworld12 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
A2 Biotherapeutics9 shared keywordsA2 Biotherapeutics develops cell therapy technology using the Tmod platform, which applies quantitative drug discovery methods to treat cancer patients.
AN2 Therapeutics9 shared keywordsAN2 Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs from its boron chemistry platform, with a pipeline spanning hematologic diseases, infectious diseases, oncology, and bone disorders. It targets diseases with significant unmet medical needs.

Companies competing with A28 Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Amici Address Section 1498 Scope in Moderna COVID-19 Infringement Appeal: In Favor of Affirmance – Patent Docspatentdocs.org · Aug 2026A28 Therapeutics Targets Tumors - San Diego Business Journalsdbj.com · Feb 2024Revolutionizing Cancer Care: The Innovative Approach of A28 Therapeuticsshoppeblack.us · Oct 2023

Frequently asked questions

What does A28 Therapeutics do?
A28 Therapeutics develops a targeted oncolytic peptide platform for treating multiple cancer types, with its lead candidate AT-101 in late-stage development for metastatic ovarian cancer with liver metastases and hepatocellular carcinoma. The company is also exploring combinations of AT-101 with immuno-oncology drugs and chemotherapy.
Who founded A28 Therapeutics?
A28 Therapeutics was founded by Stanley Lewis in 2021.
How much funding has A28 Therapeutics raised?
A28 Therapeutics has disclosed $1.9M raised across 1 round.
Where is A28 Therapeutics headquartered?
A28 Therapeutics is headquartered in La Jolla, US.